Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Uterine Cervical Neoplasms 3Prostatic Neoplasms 3Urinary Bladder Neoplasms 2Sarcoma 2Pancreatic Neoplasms 2Breast Neoplasms 2Urologic Neoplasms 1Urologic Diseases 1Urogenital Neoplasms 1Urogenital Diseases 1Urinary Bladder Diseases 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma, Ewing 1Prostate Adenocarcinoma 1Neoplasms by Site 1Neoplasms 1Neoplasm Metastasis 1Male Urogenital Diseases 1Lymphedema 1Lung Neoplasms 1Gallbladder Neoplasms 1Financial Stress 1Female Urogenital Diseases 1Endometrial Neoplasms 1Encopresis 1Cholangiocarcinoma 1Carcinoma, Transitional Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Intraductal, Noninfiltrating 1Breast Carcinoma In Situ 1

Interventions

Surveys and Questionnaires 1Radiation Dose Hypofractionation 1Quality Indicators, Health Care 1Data Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Financial Stress × Radiation Dose Hypofractionation × 90 days × Clear all
NCT03486821 2026-05-05

Ultra-hypofractionated Radiation in Prostate Cancer

University of Kansas Medical Center

Phase NA Completed
13 enrolled

Financial Stress

Data powered by HemOnc (CC BY 4.0) Colophon âš¡